SCHEMBL17797697

SCHEMBL17797697

CC(C)(C)OC(=O)N1CCCc2cc(NC(=O)OCc3ccccc3)ccc2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 10/20 0.55
SIGMAR1 Q99720 10/20 0.55
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
ESR2 Q92731 1/20 0.51
NAMPT P43490 2/20 0.45
USP30 Q70CQ3 1/20 0.45
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TMPRSS2 O15393 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17797552 0.96 TMEM97 (0.55) TMEM97SIGMAR1NPC1RAB9AESR2
SCHEMBL2181843 0.94 ESR2 (0.58) TMEM97SIGMAR1NPC1RAB9AESR2
SCHEMBL17801727 0.85 TMEM97 (0.56) TMEM97SIGMAR1NPC1RAB9AALDH1A1
SCHEMBL4930098 0.85 CTSL (0.47) TMEM97SIGMAR1NPC1RAB9AESR2
SCHEMBL30981194 0.85 NPC1 (0.46) TMEM97SIGMAR1NPC1RAB9AESR2
Iodide SCHEMBL4639203 0.84 TMEM97 (0.44) TMEM97SIGMAR1NPC1RAB9AESR2
SCHEMBL6292442 0.84 TMEM97 (0.62) TMEM97SIGMAR1NPC1RAB9AALDH1A1
SCHEMBL350596 0.84 ESR2 (0.60) TMEM97SIGMAR1NPC1RAB9AESR2
SCHEMBL17797565 0.83 TMEM97 (0.54) TMEM97SIGMAR1NPC1RAB9APSEN1
SCHEMBL3007640 0.83 KDM1A (0.49) ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160159774-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE CAR LLC (BM) 2016-06-09 US disclosed
WO-2016090079-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-06-09 WO disclosed
WO-2016090079-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159774-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 TMEM97 1731/4885SIGMAR1 545/4885NPC1 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.